Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$98.98 - $115.74 $53,350 - $62,383
-539 Reduced 11.98%
3,962 $458,000
Q2 2023

Aug 11, 2023

BUY
$96.34 - $112.38 $95,472 - $111,368
991 Added 28.23%
4,501 $463,000
Q1 2023

May 11, 2023

SELL
$107.32 - $113.5 $89,719 - $94,886
-836 Reduced 19.24%
3,510 $383,000
Q4 2022

Feb 14, 2023

SELL
$62.39 - $113.8 $178,497 - $325,581
-2,861 Reduced 39.7%
4,346 $495,000
Q3 2022

Nov 14, 2022

BUY
$58.92 - $84.67 $122,612 - $176,198
2,081 Added 40.6%
7,207 $446,000
Q2 2022

Aug 15, 2022

BUY
$79.4 - $116.36 $195,562 - $286,594
2,463 Added 92.49%
5,126 $409,000
Q1 2022

May 12, 2022

BUY
$86.42 - $109.81 $230,136 - $292,424
2,663 New
2,663 $280,000

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track E Fund Management Co., Ltd. Portfolio

Follow E Fund Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of E Fund Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on E Fund Management Co., Ltd. with notifications on news.